文献速递产科麻醉区域麻醉与超声

早产单胎与双胎剖宫产鞘内高比重罗哌卡因剂量反应比较

Comparative dose-response study of intrathecal hyperbaric ropivacaine for cesarean delivery in preterm singleton versus twin pregnancies.
PubMed 文献 · Reg Anesth Pain Med · 2024-10-08

这项双盲随机剂量反应研究纳入75例早产单胎和75例早产双胎剖宫产患者,比较鞘内高比重罗哌卡因10、12、14、16、18 mg的剂量需求。早产单胎ED50为9.9 mg、ED90为16.8 mg,早产双胎ED50为9.2 mg、ED90为15.6 mg,相对效价比0.933,两组剂量需求无差异。

要点

  • 早产单胎与双胎剖宫产鞘内高比重罗哌卡因ED50和ED90无显著差异。
  • 早产单胎ED50为9.9 mg(95%CI 7.2–11.5),ED90为16.8 mg(95%CI 14.5–22.9)。
  • 早产双胎ED50为9.2 mg(95%CI 6.4–10.8),ED90为15.6 mg(95%CI 13.6–20.6)。

核心结论

  • 早产单胎与双胎剖宫产患者鞘内高比重罗哌卡因剂量需求无差异。

研究设计与样本

  • 双盲随机剂量反应研究,纳入75例早产单胎和75例早产双胎剖宫产患者。
  • 患者随机接受10、12、14、16或18 mg高比重罗哌卡因。
  • 采用概率回归模型计算ED50和ED90,并计算相对中位效价。

主要发现

  • 早产单胎组ED50为9.9 mg(95%CI 7.2–11.5),ED90为16.8 mg(95%CI 14.5–22.9)。
  • 早产双胎组ED50为9.2 mg(95%CI 6.4–10.8),ED90为15.6 mg(95%CI 13.6–20.6)。
  • 双胎与单胎ED50比值为0.933(95%CI 0.72–1.15)。

关键数值与推荐

  • 早产单胎剖宫产鞘内高比重罗哌卡因ED50为9.9 mg,ED90为16.8 mg。
  • 早产双胎剖宫产鞘内高比重罗哌卡因ED50为9.2 mg,ED90为15.6 mg。
  • 双胎与单胎相对效价(ED50比值)为0.933(95%CI 0.72–1.15)。

临床怎么用

  • 早产剖宫产选择鞘内高比重罗哌卡因剂量时,双胎与单胎可按相同剂量策略考虑。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Previously, we demonstrated that patients with full-term singletons and preterm twins require similar dose of intrathecal hyperbaric ropivacaine. However, these findings may be attributable to enrolled patients with preterm twin pregnancies. In this study, we aimed to determine the intrathecal dose requirements of hyperbaric ropivacaine for twins and singletons at equal gestational ages. METHODS: We enrolled 75 patients with preterm singletons and 75 patients with preterm twins scheduled for cesarean delivery under combined spinal-epidural anesthesia in this two-arm parallel, randomized, double-blind, dose-response study. Patients with singletons and twins were randomly assigned to receive one of five different doses of hyperbaric ropivacaine: 10, 12, 14, 16, or 18 mg. A probit regression model was used to determine the dose effective in 50% of patients (ED50) and dose effective in 90% of patients (ED90) values. The relative median potency was calculated to compare the ED50 between patients with twins and singletons. RESULTS: Intrathecal ropivacaine ED50 and ED90 (with 95% CI) in patients with preterm singletons were 9.9 (7.2 to 11.5) mg and 16.8 (14.5 to 22.9) mg, respectively. In patients with preterm twins, these values were 9.2 (95% CI 6.4 to 10.8) mg and 15.6 (95% CI 13.6 to 20.6) mg. Between patients with preterm twins and preterm singletons, the relative potency (ED50 ratios) was 0.933 (95% CI 0.72 to 1.15). CONCLUSIONS: During preterm gestation, intrathecal hyperbaric ropivacaine dose requirements for scheduled cesarean delivery were not different between patients with twins and singletons. TRIAL REGISTRATION NUMBER: ChiCTR2100051382.

来源:Reg Anesth Pain Med,查看原文。版权归原作者所有。

引用

  1. Zhu M, Liu JJ, Shen YP, et al. Comparative dose-response study of intrathecal hyperbaric ropivacaine for cesarean delivery in preterm singleton versus twin pregnancies. Reg Anesth Pain Med. 2024. PMID: 37903623. doi:10.1136/rapm-2023-104875

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。